Bernstein becomes CMO at BioMarin
Plus: Novavax, TPG, Noema, Syndax, Prothena, Annexon, ProQR and more
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has hired Harold Bernstein as SVP, CMO and head of clinical development, Bernstein was previously VP at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). BioMarin also hired Ganesh Vedantham as SVP, technical development. He joins the company from Amgen Inc. (NASDAQ:AMGN), where he worked for almost 20 years, most recently as executive director in Singapore.
Novavax Inc. (NASDAQ:NVAX) hired Denny Kim as SVP, chief safety officer and head of global vaccine safety, a newly created position at the infectious disease company. Kim joins from Johnson & Johnson (NYSE:JNJ), where he oversaw safety strategies and activities across all therapeutic areas. The company promoted Raburn Mallory to SVP, head of clinical development, and Marco Cacciuttolo to SVP of process and analytical development from VP...